2026-03-20 · 个股论点

$SMCI监管风险或致买入机会，剥离噪音后估值约10-11倍PE。

涉及标的： $NVDA $SMCI

中文翻译

所有人都在关注$SMCI向中国走私价值数十亿美元AI芯片的事。但没有人回答这个问题：我如何从中赚钱，这是否是买入机会？我的答案是：如果$SMCI跌破约$24很多，甚至更低。在约$140亿市值时就像是买入机会。所有人看美国司法部(DOJ)的案子都觉得超微电脑完蛋了。但有两点： 1. 到目前为止公司本身似乎被隔离了（未被列为被告） 2. $SMCI向中国国有机构销售芯片早已是公开的（只是程度没达到$25亿以上），通过2024年浑水做空报告(Hindenburg short seller reports)。所以中国收入的这部分有相当一部分已经被定价了，这就是为什么$SMCI从$100以上暴跌到现在交易价$24。现在如果我们剥离表象和一些实质收入： -> $SMCI GAAP净收入去年为$10.5亿，2026财年估计约为$12.5亿，部分估计高达$15亿。然后我们剔除约$1.5亿走私利润从财务报表中：$10.5亿 -> ~$9亿？按市盈率(P/E)计算，作为成长型公司仍然相对便宜，大约10-11倍？现在看跌的风险： -> 舆论形象仍然很糟糕。你可以往垃圾堆里再加垃圾。但反正还是垃圾，没什么大变化？ -> $NVDA疏远$SMCI？（他们2024年已经这么做了）。 -> $SMCI未被列为被告，但如果美国证券交易委员会(SEC)/美国司法部(DOJ)起诉他们，那么会有大量监管费用和可能的罚款。 -> 也许会有订单取消，但如果2024年面临问题时他们没有取消订单，现在应该也没问题？现在...有没有比承担这个监管风险更好的机会？ 100%有。恐慌时会有更多下行空间吗？是的。但如果剥离噪音，$SMCI作为一家公司在约$140亿市值、按10-11倍远期盈利计算看起来很便宜。

英文原文

Everyone is looking at $SMCI smuggling billions of dollars of AI chips to China. But nobody is answering the question: How do I make money off this, and is it a good buying opportunity? My answer: If $SMCI drops much lower than ~$24 overnight. It like a buying opportunity at a ~$14B MC. Everyone looks at the DOJ case and thinks Super Micro are cooked. But two things: 1. The company itself looks insulated, so far (not named a defendant) 2. $SMCI chip sales to China state actors was already known (just not to the $2.5B+ extent), by Hindenburg short seller reports in 2024. So a decent part of the China revenue stuff was already priced in, which is why $SMCI crashed from $100+ and is now trading at $24. Now if we strip away optics and some material revenue: -> $SMCI GAAP net income was $1.05B last year, and FY 2026 is estimated to be around ~$1.25B with some estimates going to $1.5B. And then we rip away an est ~$150M in smuggled in profit out of financials: ~$1.05 billion -> ~$900M? On a P/E basis, still looks relatively cheap as a growing company, maybe ~10-11x? Now the downside: -> Optics are still trash. You can add more trash to trash. But it's still trash regardless, doesn't change much? -> $NVDA distancing itself with $SMCI? (They already did in 2024). -> $SMCI not named a defendant, but in the case SEC/DOJ goes after them, then lot of regulatory fees and possibly fines. -> Maybe order cancellations, but if they didn't cancel orders for the problems they had in 2024, it looks fine now? Now... Are there a lot better opportunities than taking this regulatory leap of faith? 100%. Is there potential more downside from panicking? Yes. But if you strip away the noise, $SMCI as a company looks cheap ~$14B at roughly 10-11x forward earnings.

在 X 上查看原推 ↗